Grey Market Premium (GMP) is an unofficial indicator of how an IPO may perform on listing day, based on demand for its shares in the grey market before listing. It can reflect short-term investor sentiment, but it does not show whether the company is fundamentally strong, fairly valued, or suitable for a longer-term investment. A more complete IPO evaluation considers the offer document, business and financials, promoter quality, valuation relative to listed peers, use of proceeds, and institutional demand.
In this blog, we'll explain how to evaluate an IPO beyond GMP, what to check in the RHP, how to assess valuation and subscription demand, and which signals can help you make a more informed decision before applying.
#What is GMP in an IPO?
Grey market premium, or GMP, is the rupee amount above an IPO's issue price at which its shares change hands unofficially before they list. If the issue price is ₹200 and the GMP is ₹80, the grey market is pricing in a listing around ₹280. These trades happen outside the recognised exchange mechanism and are settled privately between participants.
The number itself comes from a small circle of grey market dealers who read investor sentiment and early subscription trends. That is the key thing to understand about what GMP is in an IPO: it is a sentiment reading, not an official price. SEBI and the stock exchanges do not recognise or regulate the grey market, so there is no clearing house behind these trades and no legal recourse if a counterparty walks away.
#Why GMP alone can't guide your IPO review
A high grey market premium does tell you something. Studies of Indian IPOs have found that GMP tracks listing-day gains closely, so a strong positive GMP often signals a listing-day pop. If your only goal is the first day or two, it is a reasonable barometer of demand.
The problem starts when you use it as your whole IPO review. GMP reacts to short-term mood and can be inflated to attract retail interest, with no audit trail to verify it. There is no solid evidence that it predicts how a stock performs over one, three, or five years, and Indian IPOs often list at a premium yet drift lower in their first year. It says nothing about the company's earnings, debt or valuation. Treat GMP as one input among several, and never as a reason to apply on its own.
#Start with the offer document.
Every company going public files a Draft Red Herring Prospectus with SEBI, and later a Red Herring Prospectus (RHP) once the price band is set. The RHP is the primary document for judging an IPO, and you can download it free from NSE's offer documents page or the BSE public issues section. Four parts are worth your time before you apply.
- #Business and revenue quality: Read how the company actually makes money and whether that revenue is steady or lumpy. Watch for heavy dependence on one or two large customers, since losing them can hit the business hard.
- #Promoters and governance: Check the promoters' track record and whether they have faced regulatory action or defaults in the past. Complex, opaque group structures are a reason to slow down and read more carefully.
- #Risk factors and litigation: The RHP lists material risks in order of importance, including large pending cases and dependence on key licences. SEBI runs a disclosure-based system, which means it does not certify an issue as safe; it only requires the risks to be spelt out for you.
- #Objects of the issue: See where the money goes. In a fresh issue, the company receives proceeds for growth or debt reduction, whereas in an offer for sale, existing shareholders simply cash out. An issue that is almost entirely an offer for sale means little new capital reaches the business.
#Check the valuation against peers.
The RHP includes a "Basis for Issue Price" section, where you assess whether the IPO is fairly priced. It sets out the company's earnings per share, its price-to-earnings ratio at the issue price, return on net worth and net asset value, and compares them against listed peers in the same industry.
Your job is to ask whether any premium to those peers is earned. Faster growth, better margins or a cleaner balance sheet can justify paying more. A higher price tag on a company with weaker profitability or heavier debt is harder to defend. Be cautious when margins have slipped just before the IPO, or when a large chunk of the proceeds is labelled "general corporate purposes" rather than tied to a specific plan; SEBI generally caps the amount that can be allocated to general corporate purposes at 25% of the amount raised through the issue.
#Read the demand signals.
Once bidding opens, the exchanges publish live subscription data across the three investor categories: Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and retail investors. For many book-built IPOs, the net offer is broadly divided among QIBs, NIIs and retail investors, with the applicable allocation percentages determined by the SEBI ICDR framework and the specific issue structure.
Pay closest attention to institutional demand. Strong QIB subscription is generally a more meaningful signal than heavy retail demand because institutional investors conduct more thorough due diligence before committing capital. A retail category that is subscribed many times over may increase interest in the issue and reduce your allotment odds, but it says little about whether the stock is worth holding. Weak QIB participation is a caution signal, especially when the IPO is priced aggressively.
The anchor book adds another layer of context. Established mutual funds and long-only global investors can indicate stronger institutional scrutiny before the issue opens. Pre-issue lock-ins also matter because shares that become eligible for sale later can add supply to the market.
#Weighing it all up
No single check decides an IPO for you. Put the pieces together and make sure they all point the same way before you commit money. A few signals should make you step back regardless of how strong the GMP looks:
- Promoters or directors with a history of regulatory trouble or defaults.
- An issue that is almost entirely an offer for sale, with little fresh capital for the business.
- A valuation well above peers without clearly better growth or margins.
- Weak institutional demand despite aggressive pricing.
When the business is understandable, the promoters are clean, the valuation is sensible relative to peers, and institutional demand is genuine, you have a far stronger case than any grey-market number can give you. That is the difference between chasing a listing pop and investing with a plan.
#Conclusion
GMP is a useful gauge of listing-day mood, but it was never built to tell you whether a company deserves a place in your portfolio. The offer document, the valuation relative to peers, the quality of the promoters, and the strength of real institutional demand do that job.
Once you learn to read those, you stop applying on hearsay and start making decisions you can stand behind. When you are ready to apply, you can open a demat account with SMC and put this framework to work on the next issue you are weighing up.
Investments in securities markets are subject to market risks. Read all the related documents carefully before investing.
1800 11 0909
smc.care@smctradeonline.com